ZPCK

Item no.	HY-100709-250mg
Manufacturer	MedChem Express
CASRN	26049-94-5
Amount	250 mg
Quantity options	100 mg 1 ea 250 mg
Category	Inhibitors & Compound Libraries Compound Libraries
Specific against	other
Purity	99.0
Citations	[1]Zhao C, et al. Pharmacokinetics and metabolism of SL-01, a prodrug of gemcitabine, in rats. Cancer Chemother Pharmacol. 2013 Jun;71(6):1541-50.
Smiles	O=C(OCC1=CC=CC=C1)N[C@@H](CC2=CC=CC=C2)C(CCl)=O
Alias	SL-01
Shipping condition	Cool pack
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Apoptosis; Autophagy; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog
Shipping Temperature	Blue Ice
Storage Conditions	-20°C, 3 years (Powder)
Product Description	ZPCK is an oral active proagent of gemcitabine that was designed for improved oral bioavailability[1].
Manufacturer - Research Area	Cancer
Solubility	DMSO : 33 mg/mL (ultrasonic; warming)
Manufacturer - Pathway	Apoptosis; Autophagy; Cell Cycle/DNA Damage
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Request delivery time